PIK3CA and cancer: Interestingly, the result suggested a downregulation of PIK3CA mRNA levels in KIRC patients compared to normal controls in subgroup analyses based on race, gender, age, KIRC subtypes, tumor grade, cancer stages, and nodal metastasis status (Figure 1(e)).